BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Dayforce, Inc. ( NYSE- DAY ) , WideOpenWest, Inc. ( NYSE - WOW ) , STAAR Surgical Company ( Nasdaq - STAA ) , Y-mAbs Therapeutics, Inc. ( Nasdaq - YMAB )
BALA CYNWYD, Pa., Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
Alcon's Q2 Earnings Beat Estimates, Revenues Miss, Stock Plunges
ALC's Q2 earnings top estimates but revenues fall short, sending shares down more than 10% as margins tightened and 2025 sales outlook narrowed.
Predicting the Next Rule Breaker Buyout
Having a stock you own get acquired at a premium feels good at first, but what about the long-term gains that will be left behind when your chips are off the table?
URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger - AMWD, ARIS, IMXI, and STAA
NEW YORK, Aug. 18, 2025 ( GLOBE NEWSWIRE ) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC ( the "M&A Class Action Firm" ) , has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: WideOpenWest, Inc. ( NYSE - WOW ) , BankFinancial Corporation ( Nasdaq - BFIN ) , STAAR Surgical Company ( Nasdaq - STAA ) , Y-mAbs Therapeutics, Inc. ( Nasdaq - YMAB )
BALA CYNWYD, Pa., Aug. 12, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
Staar Surgical ( STAA ) International Revenue in Focus: Trends and Expectations
Examine Staar Surgical's (STAA) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, AMWD, STAA on Behalf of Shareholders - Performant Healthcare ( NASDAQ:PHLT ) , American Woodmark ( NASDAQ:AMWD )
NEW YORK, Aug. 07, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Performant Healthcare, Inc.
This Campbell's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - The Campbell's ( NASDAQ:CPB ) , Fortinet ( NASDAQ:FTNT )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Guggenheim analyst Howard Ma downgraded Informatica Inc INFA from Buy to Neutral and ...
STAAR Surgical ( STAA ) Q2 Revenue Tops 9%
STAAR Surgical ( NASDAQ:STAA ) , a medical device company specializing in implantable lenses for vision correction, released its earnings for Q2 FY2025 on August 6, 2025. The main news from the release is that both GAAP revenue and GAAP earnings per share came in ahead of analyst estimates, ...
Staar Surgical ( STAA ) Reports Q2 Loss, Beats Revenue Estimates
Staar Surgical (STAA) delivered earnings and revenue surprises of +87.50% and +6.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAA, YMAB, BASE, CORZ on Behalf of Shareholders - Core Scientific ( NASDAQ:CORZ ) , Couchbase ( NASDAQ:BASE )
NEW YORK, Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical - Staar Surgical ( NASDAQ:STAA ) , Alcon ( NYSE:ALC )
SAN DIEGO, Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of STAAR Surgical Company STAA breached their fiduciary duties in connection with the proposed sale of the Company to Alcon ALC.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company ( Nasdaq - STAA ) , Y-mAbs Therapeutics, Inc. ( Nasdaq - YMAB ) , Couchbase, Inc. ( Nasdaq - BASE ) , Core Scientific, Inc. ( Nasdaq - CORZ )
BALA CYNWYD, Pa., Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
STAA Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of STAAR Surgical to Alcon - Staar Surgical ( NASDAQ:STAA )
MONSEY, N.Y., Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of STAAR Surgical Company STAA ( "STAAR" ) to Alcon, Inc. ( "Alcon" ) for $28.00 per share in cash.
Why Is STAAR Surgical Stock Skyrocketing Tuesday? - Staar Surgical ( NASDAQ:STAA ) , Alcon ( NYSE:ALC )
Alcon to acquire STAAR Surgical for $28/share, a 51% premium, valuing the deal at $1.5 billion. EVO ICL lenses target rising high myopia cases; 500 million affected globally, 50% by 2050. The market's back, and these 3 income stocks are thriving. See them here→
Top 2 Health Care Stocks You May Want To Dump In Q3 - Smith & Nephew ( NYSE:SNN ) , Joby Aviation ( NYSE:JOBY )
As of Aug. 5, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices ...
Henry Schein ( HSIC ) Q2 Earnings Lag Estimates
Henry Schein (HSIC) delivered earnings and revenue surprises of -6.78% and +0.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Why Palantir Technologies Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - Agilon Health ( NYSE:AGL ) , Adaptimmune Therapeutics ( NASDAQ:ADAP )
Shares of Palantir Technologies Inc. PLTR rose sharply in pre-market trading after the company reported better-than-expected financial results for the second quarter and raised its full-year guidance. Palantir reported second-quarter revenue of $1.004 billion, beating analyst estimates of $939.71 ...
NeuroPace Announces Strategic CFO Transition
Appoints Patrick F. Williams as Chief Financial Officer ...
Staar Surgical ( STAA ) Reports Q1 Loss, Tops Revenue Estimates
Staar Surgical (STAA) delivered earnings and revenue surprises of 11.86% and 5.57%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
This Dycom Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Dycom Industries ( NYSE:DY ) , Abercrombie & Fitch ( NYSE:ANF )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Mizuho analyst Uy Ear initiated coverage on Tectonic Therapeutic, Inc.
Redfin, Mineralys Therapeutics, Trevi Therapeutics And Other Big Stocks Moving Higher On Monday - The Campbell's ( NASDAQ:CPB ) , Archer-Daniels Midland ( NYSE:ADM )
U.S. stocks were lower, with the Nasdaq Composite falling around 650 points on Monday. Shares of Redfin Corporation RDFN rose sharply during Monday's session after Rocket Companies announced it will acquire the company in an all-stock transaction valued at $12.50 per share.
Eye Lens Maker Staar Surgical Stock Sinks As Sales Drop To $49 Million, Analyst Downgrades - Staar Surgical ( NASDAQ:STAA )
Staar Surgical reported a Q4 2024 EPS loss of 69 cents, missing the consensus, with revenue dropping 36% to $48.9 million. The company expects 2025 ICL sales outside China to grow 9%-15% but anticipates weak first-half China sales before a rebound in H2 2025.
This PPG Industries Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Inhibikase Therapeutics ( NASDAQ:IKT ) , Axcelis Technologies ( NASDAQ:ACLS )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Teradata Posts Weak Revenue, Joins Lyft, Vertiv, Zillow And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Allison Transmission ( NYSE:ALSN ) , BlackLine ( NASDAQ:BL )
U.S. stock futures were lower this morning, with the Dow futures falling around 50 points on Wednesday. Shares of Teradata Corporation TDC fell sharply in today's pre-market trading after the company missed fourth-quarter revenue estimates and announced its CFO Claire Bramley will leave effective ...
ProDex ( PDEX ) Moves 23.0% Higher: Will This Strength Last?
ProDex (PDEX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
10% Owner Of Staar Surgical Purchased $1.95M In Stock - Staar Surgical ( NASDAQ:STAA )
It was revealed in a recent SEC filing that BROADWOOD PARTNERS LP, 10% Owner at Staar Surgical STAA made a noteworthy insider purchase on December 19,. What Happened: In a recent Form 4 filing with the U.S.
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos - Baxter Intl ( NYSE:BAX ) , DexCom ( NASDAQ:DXCM )
Last year, Morgan Stanley upgraded its outlook for the U.S. MedTech sector to "Attractive," believing the concerns around GLP-1s were already reflected in stock prices and that fundamentals were strong.
Implied Volatility Surging for STAAR Surgical ( STAA ) Stock Options
Investors need to pay close attention to STAAR Surgical (STAA) stock based on the movements in the options market lately.
Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer - Tarsus Pharmaceuticals ( NASDAQ:TARS )
IRVINE, Calif., Nov. 05, 2024 ( GLOBE NEWSWIRE ) -- Tarsus Pharmaceuticals, Inc. TARS, whose mission is to address unmet medical needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced the appointment of Elizabeth Yeu, ...
A Dive into Staar Surgical ( STAA ) International Revenue Trends and Forecasts
Evaluate Staar Surgical's (STAA) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Staar Surgical ( STAA ) Surpasses Q3 Earnings and Revenue Estimates
Staar Surgical (STAA) delivered earnings and revenue surprises of 115.79% and 1.59%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Should You Invest in the SPDR S&P Health Care Equipment ETF ( XHE ) ?
Sector ETF report for ...
Labcorp ( LH ) Q3 Earnings and Revenues Surpass Estimates
Labcorp (LH) delivered earnings and revenue surprises of 0.57% and 0.64%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Staar Surgical ( STAA ) Could be Great Choice for a Bottom Fisher
Staar Surgical (STAA) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a ...
Reasons to Add The Cooper Companies Stock to Your Portfolio Now
COO benefits from strength in its business segments. Its acquisitions are likely to drive the top line. A rise in selling, general and administrative expenses is, however, concerning.
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now
XRAY continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.
Wall Street Analysts Predict a 43.93% Upside in Staar Surgical ( STAA ) : Here's What You Should Know
The mean of analysts' price targets for Staar Surgical (STAA) points to a 43.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
4 Stocks to Buy Amid Dental Supplies Industry Challenges
Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These include BDX, MCK, COO and STAA.
Staar Surgical ( STAA ) Moves to Buy: Rationale Behind the Upgrade
Staar Surgical (STAA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Implied Volatility Surging for STAAR Surgical ( STAA ) Stock Options
Investors need to pay close attention to STAAR Surgical (STAA) stock based on the movements in the options market lately.
Why Staar Surgical ( STAA ) International Revenue Trends Deserve Your Attention
Evaluate Staar Surgical's (STAA) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Staar Surgical ( STAA ) Surpasses Q2 Earnings and Revenue Estimates
Staar Surgical (STAA) delivered earnings and revenue surprises of 32% and 4.05%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Becton Dickinson ( BDX ) Q3 Earnings Beat Estimates
Becton Dickinson (BDX) delivered earnings and revenue surprises of 5.74% and 1.57%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Staar Surgical ( STAA ) Soars 7.5%: Is Further Upside Left in the Stock?
Staar Surgical (STAA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Staar Surgical Sees Relative Strength Rating Rise To 73
On Friday, Staar Surgical ( STAA ) got an upgrade to its Relative Strength ( RS ) Rating, from 64 to 73. X IBD's proprietary RS Rating identifies technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.
Stocks Generating Improved Relative Strength: Staar Surgical
Staar Surgical ( STAA ) saw a positive improvement to its Relative Strength ( RS ) Rating on Tuesday, with an upgrade from 70 to 73. X This unique rating measures market leadership by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our ...
Don't Overlook Staar Surgical ( STAA ) International Revenue Trends While Assessing the Stock
Review Staar Surgical's (STAA) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Stocks With Rising Relative Strength: Staar Surgical
Staar Surgical ( STAA ) had its Relative Strength ( RS ) Rating upgraded from 65 to 75 Friday - a welcome improvement, but still shy of the 80 or higher score you prefer to see. X IBD's unique rating tracks price action with a 1 ( worst ) to 99 ( best ) score.
Wall Street's Insights Into Key Metrics Ahead of Staar Surgical ( STAA ) Q1 Earnings
Beyond analysts' top -and-bottom-line estimates for Staar Surgical (STAA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
